Cat. No. 1056
Biological ActivityEndogenous peptide with extremely high affinity and selectivity for μ-opioid receptors (with Ki values of 0.69, 9233 and 5240 nM for μ, δ and κ respectively).
(Modifications: Phe-3 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Goldberg et al (1998) Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J.Pharmacol.Exp.Ther. 286 1007. PMID: 9694962.
Harrison et al (1998) Differential effects of endomorphin-1, endomorphin-2, and tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes. Peptides 19 749. PMID: 9622031.
Chapman et al (1997) Distinct inhibitory effects of spinal endomorphin-1 and endomorphin-2 on evoked dorsal horn neuronal responses in the rat. Br.J.Pharmacol. 122 1537. PMID: 9422796.
Zadina et al (1997) A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386 499. PMID: 9087409.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Endomorphin-2 include:
Garzón et al (2004) RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance. Neuropsychopharmacology 29 1091. PMID: 14997173.
Do you know of a great paper that uses Endomorphin-2 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Endomorphin-2, supplier, Potent, selective, μ-opioid, mu-opioid, agonists, MOP, Receptors, OP3, Tocris Bioscience, μ Opioid Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Fluorescent opioid antagonist; fluorescent-derivative of naloxone (Cat. No. 0599)BMS 986187
Potent δ-opioid receptor positive allosteric modulator
April 1 - 5, 2017
Washington, D.C., USA